Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
Several recent trials of intravenously administered antitumour necrosis factor-alpha (TNF-α) monoclonal antibody have shown dramatic responses among patients with Crohn’s disease. These results indicate a primary role for TNF-αin the mediation of altered mucosal immune function in this disease. Clin...
Saved in:
Main Author: | Stephan R Targan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2000/409396 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
by: Vojtech Dotlacil, et al.
Published: (2025-01-01) -
Renal Cell Carcinoma in Fistulizing Crohn’s Disease Patient Who Received Anti-TNF α Therapy
by: Abdullah Mohammed Albishi, et al.
Published: (2021-01-01) -
Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
by: Ashley Fonseca, et al.
Published: (2021-01-01) -
Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients
by: Magdalena Kaniewska, et al.
Published: (2020-11-01) -
Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
by: Ignacio Marin-Jimenez, et al.
Published: (2024-01-01)